New insights in prolactin: pathological implications

被引:164
|
作者
Bernard, Valerie [1 ]
Young, Jacques [2 ]
Chanson, Philippe [2 ]
Binart, Nadine [1 ]
机构
[1] INSERM, U1185, F-94276 Le Kremlin Bicetre, France
[2] Hop Bicetre, Serv Endocrinol & Malad Reprod, F-94276 Le Kremlin Bicetre, France
关键词
GROWTH-HORMONE RECEPTOR; BREAST-CANCER RISK; FACTOR 16K HPRL; BETA-CELL MASS; ANTIANGIOGENIC FACTOR; PLASMA PROLACTIN; PERIPARTUM CARDIOMYOPATHY; EXTRAPITUITARY PROLACTIN; DIABETIC-RETINOPATHY; CYTOKINE RECEPTORS;
D O I
10.1038/nrendo.2015.36
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolactin is a hormone that is mainly secreted by lactotroph cells of the anterior pituitary gland, and is involved in many biological processes including lactation and reproduction. Animal models have provided insights into the biology of prolactin proteins and offer compelling evidence that the different prolactin isoforms each have independent biological functions. The major isoform, 23 kDa prolactin, acts via its membrane receptor, the prolactin receptor (PRL-R), which is a member of the haematopoietic cytokine superfamily and for which the mechanism of activation has been deciphered. The 16 kDa prolactin isoform is a cleavage product derived from native prolactin, which has received particular attention as a result of its newly described inhibitory effects on angiogenesis and tumorigenesis. The discovery of multiple extrapituitary sites of prolactin secretion also increases the range of known functions of this hormone. This Review summarizes current knowledge of the biology of prolactin and its receptor, as well as its physiological and pathological roles. We focus on the role of prolactin in human pathophysiology, particularly the discovery of the mechanism underlying infertility associated with hyperprolactinaemia and the identification of the first mutation in human PRLR.
引用
收藏
页码:265 / 275
页数:11
相关论文
共 50 条
  • [41] Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications
    Lo, Y. M.
    Chiu, Rossa W. K.
    JOURNAL OF PATHOLOGY, 2011, 225 (03): : 318 - 323
  • [42] Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy
    Zhang, Ning-ning
    Zhang, Yi
    Wang, Zhen-zhen
    Chen, Nai-hong
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (10) : 2448 - 2461
  • [43] Connexin 43: insights into candidate pathological mechanisms of depression and its implications in antidepressant therapy
    Ning-ning Zhang
    Yi Zhang
    Zhen-zhen Wang
    Nai-hong Chen
    Acta Pharmacologica Sinica, 2022, 43 : 2448 - 2461
  • [44] PROLACTIN CONCENTRATION UNDER PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS
    BERLE, P
    APOSTOLA.M
    ARCHIV FUR GYNAKOLOGIE, 1970, 211 (1-2): : 220 - &
  • [45] MOLECULAR HETEROGENEITY OF PROLACTIN IN PHYSIOLOGICAL AND PATHOLOGICAL HYPERPROLACTINEMIAS
    BARRERA, R
    DELPINO, D
    ROMERO, C
    PERALTA, O
    SILVA, R
    VARGAS, N
    PINEDA, G
    REVISTA MEDICA DE CHILE, 1983, 111 (11) : 3 - 3
  • [46] Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge
    Goffin, Vincent
    PHARMACOLOGY & THERAPEUTICS, 2017, 179 : 111 - 126
  • [47] New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy
    Jingmin Yang
    Yanying Chen
    Xiao Li
    Danyan Xu
    Heart Failure Reviews, 2022, 27 : 1431 - 1441
  • [48] New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy
    Yang, Jingmin
    Chen, Yanying
    Li, Xiao
    Xu, Danyan
    HEART FAILURE REVIEWS, 2022, 27 (04) : 1431 - 1441
  • [49] Editorial: New Insights into Mechanotransduction by Immune Cells in Physiological and Pathological Conditions
    Saika, Shizuya
    Veldhuis, Nicholas
    Krizaj, David
    Rahaman, Shaik O.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] HUMAN PROLACTIN - CLINICAL IMPLICATIONS
    HORROBIN, DF
    CLINICAL AND INVESTIGATIVE MEDICINE, 1978, 1 (01): : 5 - 6